How much do persons with Alzheimer's disease cost medicare?

Journal of the American Geriatrics Society

Volumn 48, Issue 6, 2000, Pages 639-646

  Taylor Jr , Donald H ^a   Sloan, Frank A ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cost of illness; Medicare

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; LIFE EXPECTANCY; LONG TERM CARE; MALE; MEDICAL PRACTICE; MEDICARE; PREDICTION;

EID: 0342313486     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb04721.x     Document Type: Article

References (26)

1. Small GW, Rabins PV, Barry PR et al. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, The Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-1371.
2. Hamdy RC, Turnbull JM, Edwards J et al. Alzheimer's Disease. A Handbook for Caregivers, 3rd Ed. St. Louis: Mosby, 1998.
3. General Accounting Office. Alzheimer's Disease: Estimates of Prevalence in the United States. Washington, DC: US General Accounting Office (GAO/ HEHE-98-16).
4. Evans DA, Scheer PP, Cook NR et al. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-289.
5. Phillips CD, Sloane P, Hawes C et al. Effects of residence in Alzheimer disease special care units on functional outcomes. JAMA 1997;278:1340-1344.
6. Gunderson CH. The impact of new pharmaceutical agents on the cost of neurological care. Neurology 1995;45:569-572.
7. LeBars PL, Katz M, Berman N et al. A Placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. JAMA 1997; 278:1327-1332.
8. Qizilbash N, Whitehead A, Higgins J et al. Cholinesterase inhibition for Alzheimer disease: A meta-analysis of the tacrine trials. JAMA 1998;280:1777-1782.
9. Burns A, Rossor M, Hecker J et al. The effects of Donepezil in Alzheimer's disease - Results from a multinational trial. Dev Geriatr Cogn Disord 1999; 10:237-44.
10. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-1264.
11. Huang L, Cartwright WS, Hu T. The economic cost of senile dementia in the United States, 1985. Public Health Rep 1988;103:1-7.
12. Max W. The economic impact of Alzheimer's disease. Neurology 1993; 43(suppl 4):S6-10.
13. Hay J, Ernst R. The economic costs of Alzheimer's disease. Am J Public Health 1987;77:1169-1175.
14. Hu T, Huang L, Cartwright WS. Evaluation of the costs of caring for the senile demented elderly: A pilot study. Gerontologist 1986;26:158-163.
15. Rice DP, Fox PJ, Max W et al. The economic burden of Alzheimer's disease care. Health Aff 1993;12:64-176.
16. Collins CE, Given BA, Given CW. Interventions with family caregivers of persons with Alzheimer's disease. Nurs Clin North Am 1994;29:195-207.
17. Cavallo MC, Fattore G. The economics and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord 1997;11:184-190.
18. Ostbye T, Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J 1994;151:1457-1464.
19. Cano C, Hennessy KD, Warren JL et al. Medicare Part A utilization and expenditures for psychiatric services: 1995. Health Care Financ Rev 1997;18: 177-193.
20. Weiner M, Powe NR, Weller WE et al Alzheimer's disease under managed care: Implications from Medicare utilisation and expenditure patterns. J Am Geriatr Soc 1998;46:762-770.
21. Newcomer R, Clay R, Luxenberg KS et al. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 1999;47:215-219.
22. Pfeiffer E. A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatric Soc 1975;23:433-441.
23. Overview and use of the public use data files of the 1982 and 1984 national long term care surveys. Durham, NC: Duke University, Center for Demographic Studies, 1998. (HCFA cooperative agreement no. 18-C-98641).
24. Fillenbaum GG. Multidimensional functional assessment of older adults; the Duke Older American Resources and Services Procedures. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
25. Sherbourne CD, Hays, RD. Marital status, social support, and health transitions in chronic disease patients. J Health Soc Behav 1990;31:328-343.
26. Medicare Payment Advisory Commission. Report to the Congress: Context for a Changing Medicare Program. Washington, DC: Medicare Payment Advisory Commission, 1998.